tm
Seeing Is Believing
tm
Seeing Is Believing
ABOS is currently covered by 5 analysts with an average price target of $7.61. This is a potential upside of $6.21 (443.57%) from yesterday's end of day stock price of $1.4.
Acumen Pharmaceuticals's activity chart (see below) currently has 18 price targets and 27 ratings on display. The stock rating distribution of ABOS is 100% BUY.
Highest price target for ABOS is $11, Lowest price target is $4, average price target is $9.
Most recent stock forecast was given by GEOFF MEACHAM from CITI on 17-Jun-2025. First documented stock forecast 26-Jul-2021.
Currently out of the existing stock ratings of ABOS, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.6 (185.71%)
$14
1 months 16 days ago
(17-Jun-2025)
0/4 (0%)
$2.78 (227.87%)
Buy
$11
$9.6 (685.71%)
4 months 5 days ago
(28-Mar-2025)
0/8 (0%)
$9.81 (824.37%)
Buy
$6
$4.6 (328.57%)
$15
11 months 18 days ago
(15-Aug-2024)
0/3 (0%)
$3.42 (132.56%)
Buy
$11
$9.6 (685.71%)
$15
1 years 4 months 6 days ago
(27-Mar-2024)
0/2 (0%)
$6.9 (168.29%)
Buy
$13
$11.6 (828.57%)
$13
1 years 11 months 24 days ago
(09-Aug-2023)
0/5 (0%)
$6.22 (91.74%)
What is ABOS (Acumen Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?
Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?
Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?
